Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Chronic graft-vs-host disease.

Literature DB >> 14625337

Chronic graft-vs-host disease.

Vikas Bhushan¹, Robert H Collins.

Abstract

Mesh：

Substances：
Immunosuppressive Agents

Year: 2003 PMID： 14625337 DOI： 10.1001/jama.290.19.2599

Source DB: PubMed Journal: JAMA ISSN： 0098-7484 Impact factor: 56.272

Keyword Cloud
Cited

× No keyword cloud information.

18 in total

Review 1. New and emerging therapies for acute and chronic graft versus host disease.

Authors: LaQuisa Hill; Amin Alousi; Partow Kebriaei; Rohtesh Mehta; Katayoun Rezvani; Elizabeth Shpall
Journal: Ther Adv Hematol Date: 2017-11-28

2. Increased mitochondrial apoptotic priming of human regulatory T cells after allogeneic hematopoietic stem cell transplantation.

Authors: Kazuyuki Murase; Haesook T Kim; O R Gregory Bascug; Yutaka Kawano; Jeremy Ryan; Ken-ichi Matsuoka; Matthew S Davids; John Koreth; Vincent T Ho; Corey Cutler; Philippe Armand; Edwin P Alyea; Bruce R Blazar; Joseph H Antin; Robert J Soiffer; Anthony Letai; Jerome Ritz
Journal: Haematologica Date: 2014-05-23 Impact factor: 9.941

3. Survivorship in Immune Therapy: Assessing Chronic Immune Toxicities, Health Outcomes, and Functional Status among Long-term Ipilimumab Survivors at a Single Referral Center.

Authors: Douglas B Johnson; Debra L Friedman; Elizabeth Berry; Ilka Decker; Fei Ye; Shilin Zhao; Alicia K Morgans; Igor Puzanov; Jeffrey A Sosman; Christine M Lovly
Journal: Cancer Immunol Res Date: 2015-02-03 Impact factor: 11.151

4. Graft-versus-host disease: part II. Management of cutaneous graft-versus-host disease.

Authors: Sharon R Hymes; Amin M Alousi; Edward W Cowen
Journal: J Am Acad Dermatol Date: 2012-04 Impact factor: 11.527

5. Influence of T-cell depletion on chronic graft-versus-host disease: results of a multicenter randomized trial in unrelated marrow donor transplantation.

Authors: Steven Z Pavletic; Shelly L Carter; Nancy A Kernan; Jean Henslee-Downey; Adam M Mendizabal; Esperanza Papadopoulos; Roger Gingrich; James Casper; Saul Yanovich; Daniel Weisdorf
Journal: Blood Date: 2005-07-26 Impact factor: 22.113

6. Differential epitope mapping of antibodies to PDC-E2 in patients with hematologic malignancies after allogeneic hematopoietic stem cell transplantation and primary biliary cirrhosis.

Authors: Roberto Bellucci; Sabine Oertelt; Meagan Gallagher; Sigui Li; Emmanuel Zorn; Edie Weller; Fabrice Porcheray; Edwin P Alyea; Robert J Soiffer; Nikhil C Munshi; M Eric Gershwin; Jerome Ritz
Journal: Blood Date: 2006-10-26 Impact factor: 22.113

Chronic graft-vs-host disease.

Review 1. New and emerging therapies for acute and chronic graft versus host disease.

2. Increased mitochondrial apoptotic priming of human regulatory T cells after allogeneic hematopoietic stem cell transplantation.

3. Survivorship in Immune Therapy: Assessing Chronic Immune Toxicities, Health Outcomes, and Functional Status among Long-term Ipilimumab Survivors at a Single Referral Center.

4. Graft-versus-host disease: part II. Management of cutaneous graft-versus-host disease.

5. Influence of T-cell depletion on chronic graft-versus-host disease: results of a multicenter randomized trial in unrelated marrow donor transplantation.

6. Differential epitope mapping of antibodies to PDC-E2 in patients with hematologic malignancies after allogeneic hematopoietic stem cell transplantation and primary biliary cirrhosis.

7. Labial fusion: a rare complication of chronic graft-versus-host disease.

8. Bronchiolitis obliterans after allogeneic hematopoietic stem cell transplantation.

9. Extracorporeal photophoresis: an evidence-based analysis.

10. High levels of B-cell activating factor in patients with active chronic graft-versus-host disease.